Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Molecular Pharmacology
|
November 14, 2013
Salicylate, a catalytic inhibitor of topoisomerase II, inhibits DNA cleavage and is selective for the α isoform
Jason T Bau, Zhili Kang, Caroline A Austin, et al.
International Journal of Cancer
|
August 21, 2008
Selenite induces topoisomerase I and II-DNA complexes in K562 leukemia cells
Miguel López-Lázaro, Elaine Willmore, Sarah L Elliott, et al.
Stem Cells (Dayton, Ohio)
|
November 8, 2014
Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha
Uri Ben-David, Ian G Cowell, Caroline A Austin, et al.
Cancer Chemotherapy and Pharmacology
|
September 25, 2003
Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity
Fiona Errington, Elaine Willmore, Chrysoula Leontiou, et al.
Plos One
|
March 13, 2008
The impact of the human DNA topoisomerase II C-terminal domain on activity
Emma L Meczes, Kathryn L Gilroy, Katherine L West, et al.
Mutagenesis
|
March 9, 2011
Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide
Miguel López-Lázaro, José Manuel Calderón-Montaño, Estefanía Burgos-Morón, et al.
Genes, Chromosomes & Cancer
|
December 12, 2013
The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1
Kayleigh A Smith, Ian G Cowell, Yanming Zhang, et al.
Nucleus (Austin, Tex.)
|
June 8, 2011
Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin
Ian G Cowell, Nikolaos Papageorgiou, Kay Padget, et al.
Molecular Pharmacology
|
June 27, 2020
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes
Rebecca L Swan, Luke L K Poh, Ian G Cowell, et al.
Nucleic Acids Research
|
March 22, 2006
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity
Kathryn L Gilroy, Chrysoula Leontiou, Kay Padget, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Molecular Pharmacology
|
November 14, 2013
Salicylate, a catalytic inhibitor of topoisomerase II, inhibits DNA cleavage and is selective for the α isoform
Jason T Bau, Zhili Kang, Caroline A Austin, et al.
International Journal of Cancer
|
August 21, 2008
Selenite induces topoisomerase I and II-DNA complexes in K562 leukemia cells
Miguel López-Lázaro, Elaine Willmore, Sarah L Elliott, et al.
Stem Cells (Dayton, Ohio)
|
November 8, 2014
Brief reports: Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha
Uri Ben-David, Ian G Cowell, Caroline A Austin, et al.
Cancer Chemotherapy and Pharmacology
|
September 25, 2003
Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity
Fiona Errington, Elaine Willmore, Chrysoula Leontiou, et al.
Plos One
|
March 13, 2008
The impact of the human DNA topoisomerase II C-terminal domain on activity
Emma L Meczes, Kathryn L Gilroy, Katherine L West, et al.
Mutagenesis
|
March 9, 2011
Green tea constituents (-)-epigallocatechin-3-gallate (EGCG) and gallic acid induce topoisomerase I- and topoisomerase II-DNA complexes in cells mediated by pyrogallol-induced hydrogen peroxide
Miguel López-Lázaro, José Manuel Calderón-Montaño, Estefanía Burgos-Morón, et al.
Genes, Chromosomes & Cancer
|
December 12, 2013
The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1
Kayleigh A Smith, Ian G Cowell, Yanming Zhang, et al.
Nucleus (Austin, Tex.)
|
June 8, 2011
Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin
Ian G Cowell, Nikolaos Papageorgiou, Kay Padget, et al.
Molecular Pharmacology
|
June 27, 2020
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes
Rebecca L Swan, Luke L K Poh, Ian G Cowell, et al.
Nucleic Acids Research
|
March 22, 2006
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activity
Kathryn L Gilroy, Chrysoula Leontiou, Kay Padget, et al.
Page
of 8